Back to conference program

Health benefits of Vitamin K2

11:00 am - 12:00 pm
(All times are EDT America/New_York )

The topic:

Natural vitamin K2 plays an essential role in bone and vascular health. In bone it activates osteocalcin, a protein important for optimal bone strength, whereas in the arteries K2 activates MGP, the most powerful calcification inhibitor presently known. Substantial health benefits may be expected from increased vitamin K2 intake, notably for those at risk for increased bone loss or vascular calcification.

Moderator

Dan Edwall NattoPharma Dan Edwall
Vice President R&D
NattoPharma

Dan Edwall holds a PhD in cellular and molecular biology from the Karolinska Institute in Stockholm, Sweden where he also trained as a licensed dentist. Following this, Dr. Edwall did his postdoctoral training as a research fellow at the Mineral Metabolism Unit of Loma Linda University in California, USA, and has subsequently worked with preclinical pharmacology in the Swedish pharmaceutical industry (Pharmacia), and as the director of research for Accuro Immunology, a biotech company. Since 2006, he has been conducting research in food supplements with Scandinavian Clinical Nutrition, and Scandivir.

NattoPharma

Speaker

Cees Vermeer NattoPharma Cees Vermeer
CEO of VitaK BV / R&D Partner with
NattoPharma

Cees Vermeer (64) is Associate Professor of Biochemistry at the Maastricht University and since 10 years also CEO of VitaK, a spin-off company focusing on research on vitamin K and vitamin K-dependent proteins. VitaK employs 14 researchers (PhD, MSc, and BSc) who are all working on a) clinical trials to demonstrate health effects of vitamin K, b) development of new biomarkers based on vitamin K-dependent proteins and c) analysis of K-vitamins in foods and body fluids. Cees Vermeer has been the supervisor of 16 PhD students and is an author in over 300 papers in the international scientific press. VitaK is specialized in bone and cardiovascular health and has a long-standing R&D collaboration with NattoPharma; we have demonstrated the quality and health effects of MenaQ7 in several independent clinical trials and also act as consultant for scientific and regulatory affairs as well as for designing and defending IPR.

NattoPharma